Health Canada, Novavax and COVID-19 vaccine
If you've received the COVID-19 vaccine, you may have experienced common side effects such as pain, fatigue, or fever, or ...
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...
If Novavax's JN.1 vaccine does get approved, provinces and territories "may choose to procure independently from Novavax from supply produced in India for their fall vaccination campaigns," he ...
However, with COVID-19 stubbornly sticking around, investors should focus on an obscure, up-and-coming COVID-19 vaccine maker called Novavax. Novavax (NVAX) is a biotech company that develops ...